These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37248819)

  • 21. Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke.
    Tiedt S; Duering M; Barro C; Kaya AG; Boeck J; Bode FJ; Klein M; Dorn F; Gesierich B; Kellert L; Ertl-Wagner B; Goertler MW; Petzold GC; Kuhle J; Wollenweber FA; Peters N; Dichgans M
    Neurology; 2018 Oct; 91(14):e1338-e1347. PubMed ID: 30217937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
    Meregalli C; Fumagalli G; Alberti P; Canta A; Chiorazzi A; Monza L; Pozzi E; Carozzi VA; Blennow K; Zetterberg H; Cavaletti G; Marmiroli P
    Arch Toxicol; 2020 Jul; 94(7):2517-2522. PubMed ID: 32333051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.
    Thebault S; R Tessier D; Lee H; Bowman M; Bar-Or A; Arnold DL; L Atkins H; Tabard-Cossa V; Freedman MS
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e598. PubMed ID: 31516913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury.
    Wentz E; Dobrescu SR; Dinkler L; Gillberg C; Gillberg C; Blennow K; Råstam M; Zetterberg H
    Eur Child Adolesc Psychiatry; 2021 Dec; 30(12):1907-1915. PubMed ID: 33040187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
    Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
    Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
    Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
    J Neuroinflammation; 2018 Jul; 15(1):209. PubMed ID: 30021640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.
    Kammeyer R; Mizenko C; Sillau S; Richie A; Owens G; Nair KV; Alvarez E; Vollmer TL; Bennett JL; Piquet AL
    Front Neurol; 2022; 13():689975. PubMed ID: 35309573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
    Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
    J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofilament Light Chain Is a Promising Biomarker in Alcohol Dependence.
    Li Y; Duan R; Gong Z; Jing L; Zhang T; Zhang Y; Jia Y
    Front Psychiatry; 2021; 12():754969. PubMed ID: 34867542
    [No Abstract]   [Full Text] [Related]  

  • 30. Serum neurofilament light is sensitive to active cerebral small vessel disease.
    Gattringer T; Pinter D; Enzinger C; Seifert-Held T; Kneihsl M; Fandler S; Pichler A; Barro C; Gröbke S; Voortman M; Pirpamer L; Hofer E; Ropele S; Schmidt R; Kuhle J; Fazekas F; Khalil M
    Neurology; 2017 Nov; 89(20):2108-2114. PubMed ID: 29046363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
    Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
    Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population.
    Gleerup HS; Sanna F; Høgh P; Simrén J; Blennow K; Zetterberg H; Hasselbalch SG; Ashton NJ; Simonsen AH
    Front Aging Neurosci; 2021; 13():659898. PubMed ID: 34040512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study.
    Ljungqvist J; Zetterberg H; Mitsis M; Blennow K; Skoglund T
    J Neurotrauma; 2017 Mar; 34(5):1124-1127. PubMed ID: 27539721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Neurofilament Light Concentration Is Associated with Diffusion-Tensor MRI-Based Measures of Neurodegeneration in Early Parkinson's Disease.
    Welton T; Tan YJ; Saffari SE; Ng SYE; Chia NSY; Yong ACW; Choi X; Heng DL; Shih YC; Hartono S; Lee W; Xu Z; Tay KY; Au WL; Tan EK; Chan LL; Ng ASL; Tan LCS
    J Parkinsons Dis; 2022; 12(7):2135-2146. PubMed ID: 36057833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of
    Portero M; Miró G; Checa R; Martínez de Merlo E; Fragío C; Benito M; Sainz Á; Pérez C
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Weston PSJ; Poole T; Ryan NS; Nair A; Liang Y; Macpherson K; Druyeh R; Malone IB; Ahsan RL; Pemberton H; Klimova J; Mead S; Blennow K; Rossor MN; Schott JM; Zetterberg H; Fox NC
    Neurology; 2017 Nov; 89(21):2167-2175. PubMed ID: 29070659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurofilament Light Chain as A Biomarker for Brain Metastases.
    Winther-Larsen A; Hviid CVB; Meldgaard P; Sorensen BS; Sandfeld-Paulsen B
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33023150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.